Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Mowi Genetics AS
AS
Active
Org 922025045
Sandviksbodene 77A, 5035
Bergen
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2019 · 7 years old
9 employees
www.mowi.com
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Mowi Genetics AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
123M
92M
62M
31M
0M
2020: 38M
38M
2020
2021: 38M (0% vs 2020)
38M
0%
2021
2022: 39M (+3% vs 2021)
39M
+3%
2022
2023: 99M (+154% vs 2022)
99M
+154%
2023
2024: 28M (-72% vs 2023)
28M
-72%
2024
EBITDA
NOK millions
75M
56M
37M
19M
0M
2020: 1M
1M
2020
2021: 5M (+400% vs 2020)
5M
+400%
2021
2022: 0M (-100% vs 2021)
0M
-100%
2022
2023: 60M
60M
2023
2024: 3M (-95% vs 2023)
3M
-95%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
27 609
99 139
38 744
38 324
38 072
Staff expenses
−7 875
−8 079
−7 748
−7 394
−7 062
EBITDA
3 123
59 889
−322
4 674
997
Depreciation & amort.
−71
−71
−71
−71
−17
EBIT
3 052
59 818
−392
4 603
980
Net financials
−486
−454
−630
−347
−1 991
Profit before tax
2 566
59 364
−1 023
4 256
−1 012
Tax
416
12 494
−225
792
−350
Net profit
2 150
46 870
−798
3 464
−662
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
27 832
83 078
22 908
19 075
16 103
Equity
10 239
51 578
4 708
5 506
2 042
Long-term debt
45
49
0
49
43
Short-term debt
17 548
31 451
18 200
13 520
14 018
Total debt
17 593
31 500
18 200
13 569
14 061
Financial ratios
5-year trend
EBITDA margin
11,3 %
This company
15,8 %
Market median
This company
Market median
28% below market
2020
2024
Equity ratio
36,8 %
This company
38,2 %
Market median
This company
Market median
4% below market
2020
2024
Return on equity
21,0 %
This company
18,4 %
Market median
This company
Market median
14% above market
2020
2024
Net profit margin
7,8 %
This company
8,1 %
Market median
This company
Market median
4% below market
2020
2024
Asset turnover
0,99×
This company
1,12×
Market median
This company
Market median
12% below market
2020
2024
Debt / equity
1,72×
This company
0,62×
Market median
This company
Market median
177% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Mowi Genetics AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
